Risk factors of microbiological ineffectiveness of complex probiotic therapy against obligate intestinal microflora in patients with multidrug-resistant tuberculosis

The aim of the work was to identify risk factors for the absence of a microbiological effect when using complex probiotic therapy in patients with drug-resistant tuberculosis.

Material and methods. The object of the study was 30 patients with tuberculosis in the course of anti-tuberculosis therapy, who received a course of complex probiotic therapy. The patients were divided into groups according to the microbiological effect of using the probiotic against Bifido and Lactobacterium spp .: Group 1 – restoration of Lactobacterium spp. Happened, 2 – did not happen, 1A – recovery of Bifidobacterium spp. Happened, 1B did not happen. With the help of statistical processing of the material, the main risk factors for reducing its effectiveness have been identified.

Research results. Among all factors (gender, social status, HIV infection, immunodeficiency, smoking, alcohol dependence, clinical form of tuberculosis and anti-tuberculosis drugs taken), the risk of reducing the efficiency of the Lactobacterium spp. in tuberculosis patients it is shown in males (OR 2.500, p = 0.029) over the age of 50 (p = 0.008). However, a significant decrease in the effectiveness of complex probiotic therapy to restore the pool of Lactobacterium spp. in the intestinal biotope is statistically significant due to the male sex (OR 8,000, p = 0.013 and the number of CD4 + lymphocytes (p = 0.005).

Conclusion. The main risk factors for a decrease in the rate of recovery of the pool of Lactobacterium spp. in patients with multidrug-resistant tuberculosis, the pathogen was male and female, and the recovery of the Bifidobacterium spp. depended on the male sex and the severity of immunodeficiency in the presence of HIV infection.

1. Lee B.J., Bak Y.T. Irritable bowel syndrome, gut microbiota and probiotics // J. Neurogastroenterol. Motil. 2011. Vol. 17, N 3. P. 252–266.

2. Pagnini C., Corleto V.D., Martorelli M., Lanini C., D’Ambra G., Di Giulio E. et al. Mucosal adhesion and anti-infl ammatory eff ects of Lactobacillus rhamnosus GG in the human colonic mucosa: a proof-of-concept study // World J. Gastroenterol. 2018. Vol. 24, N 41. P. 4652–4662.

3. Yuan F., Ni H., Asche C.V., Kim M., Walayat S., Ren J. Effi cacy of Bifi dobacterium infantis 35 624 in patients with irritable bowel syndrome: a meta-analysis // Curr. Med. Res. Opin. 2017. Vol. 33, N 7. P. 1191–1197.

4. Yu D. et al. Influence of oral nutritional agents rich in soluble dietary fiber on intestinal flora of elderly men with malnutrition //Aging Medicine. – 2021. – Т. 4. – №. 3. – С. 162-168.

5. Jayanama K., Theou O. Effects of probiotics and prebiotics on frailty and ageing: a narrative review //Current clinical pharmacology. – 2020. – Т. 15. – №. 3. – С. 183-192.

6. Ermolenko KD et al. The need for individual selection of probiotics containing lactobacilli and enterococci to improve the effectiveness of therapy for campylobacteriosis // Experimental and clinical gastroenterology. – 2021. – No. 2. – S. 88-93.

7. Bondarenko VM, Rybalchenko OV Therapeutic effect of probiotics // Gastoroenterology of St. Petersburg. – 2009. – No. 1. – S. 2-3.

8. Darmov IV et al. Survival of microorganisms of probiotics in vitro, simulating the process of digestion in humans // Experimental and clinical gastroenterology. – 2011. – No. 3.

9. Bomshtein N. G. et al. The effectiveness of sorbed probiotics in the complex treatment of a new coronavirus infection COVID-19 in a hospital environment // Medicine of extreme situations. – 2020. – T. 22. – No. 4. – S. 31-35.

10. Skrynnikova TI, Gryazneva TN, Le TN A. Evaluation of the effectiveness of probiotics based on different strains of bacilli in an experiment on a biological model of salmonellosis // Veterinary Medicine, Animal Science and Biotechnology. – 2020. – No. 5. – S. 28-31.

11. Zheng D. W. et al. Prebiotics Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer // Advanced Materials. – 2020. – Т. 32. – №. 45. – С. 2004529.

12. Nagibovich O. A., Subbotina T. I., Reshetkina D. A. Using the achievements of biotechnology in the treatment of diabetes // News of the Russian Military Medical Academy. – 2020. – T. 39. – No. S3-3. – S. 136-142.

13. Plotnikova E. Yu., Zakharova Yu. V. Immunomodulating effects of probiotics // Medical Council. – 2020. – No. 15.

14. Zakharova Yu. V. et al. Intestinal microbiocenosis of children at different stages of HIV infection // Immunopathology, Allergology, Infectology. – 2020. – No. 2. – S. 90-95.

15. Ashuro A. A. et al. Review on the alteration of gut microbiota: the role of HIV infection and old age //AIDS research and human retroviruses. – 2020. – Т. 36. – №. 7. – С. 556-565.

16. Martínez-Martínez M.I., Calabuig-Tolsá R., Cauli O. The eff ect of probiotics as a treatment for constipation in elderly people: a systematic review // Arch. Gerontol. Geriatr. 2017. Vol. 71. P. 142–149.

17. Lewis S., Potts L., Barry R. // J. Infect. – 1998. – Vol. 36. – P. 171–174.